Effect of Transcutaneous Auricular Vagus Nerve Stimulation in Chronic Low Back Pain: A Pilot Study
2024

Vagus Nerve Stimulation for Chronic Low Back Pain

Sample size: 30 publication 10 minutes Evidence: moderate

Author Information

Author(s): Tavares-Figueiredo Isabelle, Pers Yves-Marie, Duflos Claire, Herman Fanchon, Sztajnzalc Benjamin, Lecoq Hugo, Laffont Isabelle, Dupeyron Arnaud F., Homs Alexis F.

Primary Institution: Montpellier University Hospital

Hypothesis

Can transcutaneous auricular vagus nerve stimulation (taVNS) reduce pain and improve functional outcomes in patients with chronic low back pain (CLBP)?

Conclusion

The study suggests that taVNS is a feasible, safe, and potentially effective treatment for CLBP.

Supporting Evidence

  • VAS scores decreased significantly by 16.1 mm after 1 month.
  • Functional disability improved with an average reduction in ODI of 11.9 points after 3 months.
  • 51.9% of patients achieved clinically meaningful pain reduction.

Takeaway

This study tested a device that stimulates a nerve in the ear to help people with back pain feel better. Many patients felt less pain after using it for three months.

Methodology

Thirty adults with CLBP were treated with a taVNS device on the left ear for 30 minutes daily over three months, measuring pain intensity and functional outcomes.

Potential Biases

Potential bias due to the open-label design and reliance on patient-reported outcomes.

Limitations

The study lacked a control group, making it difficult to attribute improvements solely to taVNS.

Participant Demographics

Participants were adults aged 18 to 70 years with chronic low back pain.

Statistical Information

P-Value

<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.3390/jcm13247601

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication